HOPX
HOPX (HOP homeobox, also known as homeodomain-only protein, LAGY, HOP, OB1, NECC1 and SMAP31) is an atypical homeodomain protein that does not bind DNA. It modulates cardiac growth and development through its interaction with SRF, and also acts as a co-chaperone for HSPA1A and HSPA1B. Browse Assay Genie's current range of HOPX research reagents below, or read on for the biology behind the target.
HOPX is an atypical homeodomain protein that does not bind DNA and is required to modulate cardiac growth and development. It acts through its interaction with serum response factor (SRF), and so influences the expression of SRF-dependent cardiac-specific genes. It prevents SRF-dependent transcription either by inhibiting SRF binding to DNA or by recruiting histone deacetylase (HDAC) proteins that block transcription by SRF. Overexpression of HOPX causes cardiac hypertrophy. The protein also acts as a co-chaperone for the chaperones HSPA1A and HSPA1B, and assists in chaperone-mediated protein refolding.
The HOPX gene encodes a homeodomain protein that lacks certain conserved residues required for DNA binding, which explains its unusual mode of action through protein partners rather than direct promoter contact. UniProt records the protein in both the nucleus and the cytoplasm. Multiple alternatively spliced transcript variants have been identified for the gene. HGNC places it in the PRD class homeoboxes and pseudogenes group. Mouse and rat orthologs are both named Hopx, and studies in mice support the interaction with SRF and a role in cardiac development.
HOPX has also been linked to cancer biology. Choriocarcinoma cell lines and tissues were reported to fail to express the gene, which suggested a possible involvement in the malignant conversion of placental trophoblasts, and UniProt notes that HOPX may act as a tumour suppressor. Researchers studying HOPX protein or HOPX gene expression work across cardiac biology, transcriptional regulation and tumour biology.
HOPX is required to modulate cardiac growth and development, and its overexpression causes cardiac hypertrophy.
HOPX interacts with SRF and blocks SRF-dependent transcription, by inhibiting DNA binding or recruiting HDAC proteins.
HOPX may act as a tumour suppressor, and its loss of expression in choriocarcinoma points to a role in trophoblast malignancy.
HOPX acts as a co-chaperone for HSPA1A and HSPA1B and assists in chaperone-mediated protein refolding.
HOPX is an atypical homeodomain protein that does not bind DNA. It interacts with SRF to modulate SRF-dependent cardiac gene expression, either by blocking SRF binding to DNA or by recruiting HDAC proteins. It also acts as a co-chaperone for HSPA1A and HSPA1B.
HOPX stands for HOP homeobox, and UniProt calls the protein homeodomain-only protein. Aliases include LAGY, HOP, OB1, NECC1 and SMAP31. The NCBI Gene summary notes that multiple alternatively spliced transcript variants have been identified for this gene.
Mouse and rat both have a Hopx ortholog, and mouse studies support its SRF interaction and cardiac role. Overexpression causes cardiac hypertrophy, and HOPX may act as a tumour suppressor. Check the datasheet of any product for its validated reactivity.
Serum response factor, HSP70 chaperones and histone deacetylases linked to HOPX function, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9BPY8; product specifications from Assay Genie datasheets.